Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 04-May-23 7:44 AM View:  | Jounce Therapeutics, Inc. (JNCE) | 03-May-23 | Disposition (change in control) | 188,778 | -- | -- | (100%) 188.78K to 1 | |
| 06-Apr-23 4:37 PM View: | Jounce Therapeutics, Inc. (JNCE) | 04-Apr-23 | Sale (Planned) | 39,228 | $1.85 | $72,571.80 | (17%) 228.01K to 188.78K | |
| 11-Jan-23 8:32 PM View: | Jounce Therapeutics, Inc. (JNCE) | 10-Jan-23 | Sale | 24,879 | $1.12 | $27,864.50 | (10%) 252.89K to 228.01K | |
| 11-Jan-23 8:32 PM View: | Jounce Therapeutics, Inc. (JNCE) | 09-Jan-23 | Sale | 20,191 | $1.10 | $22,210.10 | (7%) 273.08K to 252.89K | |
| 03-Feb-22 7:37 PM View: | Jounce Therapeutics, Inc. (JNCE) | 01-Feb-22 | Grant | 87,500 | -- | -- | 47% 185.58K to 273.08K | |
| 11-Jan-22 8:57 PM View: | Jounce Therapeutics, Inc. (JNCE) | 10-Jan-22 | Market Sale | 23,924 | $6.65 | $159,095.00 | (11%) 209.5K to 185.58K | (2%) |
| 11-Jan-22 8:57 PM View: | Jounce Therapeutics, Inc. (JNCE) | 07-Jan-22 | Market Sale | 13,370 | $7.30 | $97,601.00 | (6%) 222.87K to 209.5K | 7% |
| 03-Feb-21 5:48 PM View: | Jounce Therapeutics, Inc. (JNCE) | 03-Feb-21 | Grant | 7,500 | -- | -- | 3% 215.37K to 222.87K | |
| 03-Feb-21 5:48 PM View: | Jounce Therapeutics, Inc. (JNCE) | 01-Feb-21 | Grant | 75,000 | -- | -- | 53% 140.37K to 215.37K | |
| 25-Jan-21 5:38 PM View: | Jounce Therapeutics, Inc. (JNCE) | 21-Jan-21 | Option Exercise | 33,518 | $0.48 | $16,088.60 | 24% 140.37K to 173.89K | |
| 25-Jan-21 5:38 PM View: | Jounce Therapeutics, Inc. (JNCE) | 21-Jan-21 | Market Option Sale (Planned) | 33,518 | $12.06 | $404,227.00 | (19%) 173.89K to 140.37K | |
| 20-Jan-21 8:38 PM View: | Jounce Therapeutics, Inc. (JNCE) | 20-Jan-21 | Option Exercise | 16,482 | $0.48 | $7,911.36 | 12% 140.37K to 156.85K | |
| 20-Jan-21 8:38 PM View: | Jounce Therapeutics, Inc. (JNCE) | 20-Jan-21 | Market Option Sale (Planned) | 16,482 | $12.04 | $198,443.00 | (11%) 156.85K to 140.37K | |
| 20-Jan-21 8:38 PM View: | Jounce Therapeutics, Inc. (JNCE) | 19-Jan-21 | Option Exercise | 40,000 | $0.48 | $19,200.00 | 28% 140.37K to 180.37K | |
| 20-Jan-21 8:38 PM View: | Jounce Therapeutics, Inc. (JNCE) | 19-Jan-21 | Market Option Sale (Planned) | 40,000 | $9.59 | $383,600.00 | (22%) 180.37K to 140.37K | |
| 20-Jan-21 8:38 PM View: | Jounce Therapeutics, Inc. (JNCE) | 15-Jan-21 | Option Exercise | 30,000 | $0.48 | $14,400.00 | 21% 140.37K to 170.37K | |
| 20-Jan-21 8:38 PM View: | Jounce Therapeutics, Inc. (JNCE) | 15-Jan-21 | Market Option Sale (Planned) | 30,000 | $8.54 | $256,200.00 | (18%) 170.37K to 140.37K | |
| 11-Jan-21 6:21 AM View: | Jounce Therapeutics, Inc. (JNCE) | 08-Jan-21 | Market Sale | 11,816 | $7.00 | $82,712.00 | (8%) 152.19K to 140.37K | (4%) |
| 11-Jan-21 6:21 AM View: | Jounce Therapeutics, Inc. (JNCE) | 07-Jan-21 | Market Sale | 10,183 | $6.76 | $68,837.10 | (6%) 162.37K to 152.19K | (8%) |
| 04-Feb-20 9:01 PM View: | Jounce Therapeutics, Inc. (JNCE) | 03-Feb-20 | Grant | 75,010 | -- | -- | 86% 87.36K to 162.37K | |
| 10-Jan-20 8:53 AM View: | Jounce Therapeutics, Inc. (JNCE) | 07-Jan-20 | Market Sale | 7,150 | $7.78 | $55,627.00 | (8%) 94.51K to 87.36K | 17% |
| 26-Dec-19 5:08 PM View: | Jounce Therapeutics, Inc. (JNCE) | 23-Dec-19 | Option Exercise | 40,000 | $0.48 | $19,200.00 | 42% 94.51K to 134.51K | |
| 26-Dec-19 5:08 PM View: | Jounce Therapeutics, Inc. (JNCE) | 23-Dec-19 | Market Option Sale (Planned) | 40,000 | $8.37 | $334,800.00 | (30%) 134.51K to 94.51K | 23% |
| 05-Feb-19 6:00 PM View: | Jounce Therapeutics, Inc. (JNCE) | 01-Feb-19 | Grant | 62,510 | -- | -- | 195% 32.0K to 94.51K | |
| 07-Sep-18 4:48 PM View: | Jounce Therapeutics, Inc. (JNCE) | 06-Sep-18 | Option Exercise | 32,000 | $0.48 | $15,360.00 | 100% 0 to 32.0K | |
| 12-Mar-18 7:06 PM View: | Jounce Therapeutics, Inc. (JNCE) | 08-Mar-18 | Option Exercise | 16,334 | $0.48 | $7,840.32 | 100% 0 to 16.33K | |
| 12-Mar-18 7:06 PM View: | Jounce Therapeutics, Inc. (JNCE) | 08-Mar-18 | Market Option Sale (Planned) | 16,334 | $25.10 | $409,983.00 | (100%) 16.33K to 0 | 74% |
| 07-Mar-18 6:59 PM View: | Jounce Therapeutics, Inc. (JNCE) | 05-Mar-18 | Option Exercise | 16,334 | $0.48 | $7,840.32 | 100% 0 to 16.33K | |
| 07-Mar-18 6:59 PM View: | Jounce Therapeutics, Inc. (JNCE) | 05-Mar-18 | Market Option Sale (Planned) | 16,334 | $21.43 | $350,043.00 | (100%) 16.33K to 0 | 70% |
| 22-Jul-08 6:06 PM View: | PDL BioPharma Inc. (PDLI) | 21-Jul-08 | Payment of Exercise | 1,519 | $10.98 | $16,678.60 | (2%) 71.68K to 70.16K | 26% |
| 16-Jul-08 1:00 PM View: | PDL BioPharma Inc. (PDLI) | 14-Jul-08 | Payment of Exercise | 1,447 | $10.56 | $15,280.30 | (2%) 73.13K to 71.68K | 24% |
| 30-Apr-08 6:07 PM View: | PDL BioPharma Inc. (PDLI) | 28-Apr-08 | Option Exercise | 20,000 | $7.85 | $157,000.00 | 38% 53.13K to 73.13K | 69% |
| 24-Jul-07 5:37 PM View: | PDL BioPharma Inc. (PDLI) | 20-Jul-07 | Payment of Exercise | 1,519 | $25.93 | $39,387.70 | (3%) 53.13K to 51.61K | 55% |
| 17-Jul-07 6:38 PM View: | PDL BioPharma Inc. (PDLI) | 13-Jul-07 | Payment of Exercise | 1,447 | $26.22 | $37,940.30 | (3%) 54.57K to 53.13K | 56% |
| 24-Jul-06 10:00 PM View: | PDL BioPharma Inc. (PDLI) | 20-Jul-06 | Grant | 17,000 | -- | -- | 45% 37.57K to 54.57K | |
| 17-Jul-06 5:58 PM View: | PDL BioPharma Inc. (PDLI) | 13-Jul-06 | Payment of Exercise | 1,448 | $17.40 | $25,195.20 | (4%) 39.02K to 37.57K | 33% |
| 07-Mar-06 5:28 PM View: | PDL BioPharma Inc. (PDLI) | 06-Mar-06 | Market Option Sale (Planned) | 12,673 | $32.00 | $405,536.00 | (25%) 51.69K to 39.02K | 64% |
| 07-Mar-06 5:28 PM View: | PDL BioPharma Inc. (PDLI) | 03-Mar-06 | Option Exercise | 15,000 | $8.77 | $131,625.00 | 57% 26.35K to 41.35K | |
| 07-Mar-06 5:28 PM View: | PDL BioPharma Inc. (PDLI) | 03-Mar-06 | Market Option Sale (Planned) | 2,327 | $32.02 | $74,510.50 | (6%) 41.35K to 39.02K | 64% |
| 08-Sep-05 6:41 PM View: | PDL BioPharma Inc. (PDLI) | 06-Sep-05 | Option Exercise | 10,000 | $10.39 | $103,934.00 | 26% 39.02K to 49.02K | (85%) |
| 08-Sep-05 6:41 PM View: | PDL BioPharma Inc. (PDLI) | 06-Sep-05 | Market Option Sale (Planned) | 10,000 | $28.78 | $287,774.00 | (20%) 49.02K to 39.02K | 60% |
| 05-Aug-05 6:24 PM View: | PDL BioPharma Inc. (PDLI) | 03-Aug-05 | Option Exercise | 21,687 | $7.85 | $170,243.00 | 44% 49.02K to 70.71K | |
| 05-Aug-05 6:24 PM View: | PDL BioPharma Inc. (PDLI) | 03-Aug-05 | Market Option Sale (Planned) | 21,687 | $26.17 | $567,451.00 | (31%) 70.71K to 49.02K | 56% |
| 05-Aug-05 6:24 PM View: | PDL BioPharma Inc. (PDLI) | 03-Aug-05 | Market Sale (Planned) | 10,000 | $26.17 | $261,655.00 | (20%) 49.02K to 39.02K | 56% |
| 15-Jul-05 6:01 PM View: | PDL BioPharma Inc. (PDLI) | 13-Jul-05 | Grant | 16,200 | -- | -- | 49% 32.82K to 49.02K | |
| 22-Jun-05 5:21 PM View: | PDL BioPharma Inc. (PDLI) | 20-Jun-05 | Option Exercise | 10,500 | $7.85 | $82,425.00 | 24% 43.32K to 53.82K | (40%) |
| 22-Jun-05 5:21 PM View: | PDL BioPharma Inc. (PDLI) | 20-Jun-05 | Market Option Sale (Planned) | 10,500 | $20.00 | $210,000.00 | (20%) 53.82K to 43.32K | 42% |
| 22-Jun-05 5:21 PM View: | PDL BioPharma Inc. (PDLI) | 20-Jun-05 | Market Sale (Planned) | 10,500 | $20.00 | $210,000.00 | (24%) 43.32K to 32.82K | 42% |
| 02-Feb-05 1:46 PM View: | PDL BioPharma Inc. (PDLI) | 01-Feb-05 | Option Exercise | 2,500 | $7.85 | $19,625.00 | 5% 45.82K to 48.32K | |
| 02-Feb-05 1:46 PM View: | PDL BioPharma Inc. (PDLI) | 01-Feb-05 | Market Option Sale (Planned) | 2,500 | $20.06 | $50,151.50 | (5%) 48.32K to 45.82K | 42% |